Evidence mapPaperPMID 39199163Full record

ArticleAntioxidants (Basel, Switzerland)2024

Linalool and Geraniol Defend Neurons from Oxidative Stress, Inflammation, and Iron Accumulation in In Vitro Parkinson's Models.

Edina Pandur, Balázs Major, Tibor Rák, Katalin Sipos, Adrienne Csutak, Györgyi Horváth

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Novel cyclic CCancer cell international · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Synthetic Cyclic CAntioxidants (Basel, Switzerland) · 2025
    Article
  12. Review
  13. Macrotranscriptomics analysis for decoding the role ofFrontiers in bioengineering and biotechnology · 2025
    Article
  14. The volatile oil ofFrontiers in pharmacology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Edina PandurDepartment of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, 7624 Pécs, Hungary.ORCID 0000-0001-5012-3242
Balázs MajorDepartment of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, 7624 Pécs, Hungary.
Tibor RákDepartment of Ophthalmology, Medical School-Clinical Centre, University of Pécs, 7624 Pécs, Hungary.ORCID 0000-0002-7652-3583
Katalin SiposDepartment of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, 7624 Pécs, Hungary.ORCID 0000-0002-6706-2682
Adrienne CsutakDepartment of Ophthalmology, Medical School-Clinical Centre, University of Pécs, 7624 Pécs, Hungary.ORCID 0000-0002-7821-2412
Györgyi HorváthDepartment of Pharmacognosy, Faculty of Pharmacy, University of Pécs, 7624 Pécs, Hungary.ORCID 0000-0001-5344-0294

Funding

University of Pécs, Faculty of Pharmacy - Clinical Centre Collaboration Funding (PTE GYTK-KK Kollab 2024 PTE-GYTK-KK 2024
6 · The paper itself

Abstract

Parkinson's disease is one of the most prevalent neurological disorders affecting millions of people worldwide. There is a growing demand for novel and natural substances as complementary therapies. Essential oils and their various compounds are highly investigated natural plant-based products as potential treatment options for common human diseases, such as microbial infections, chronic diseases, and neurodegenerative disorders. The present study focuses on the beneficial effects of linalool and geraniol, the major compounds of lavender (

Indexed as

antioxidantgeraniolinflammationironlinaloolParkinson’s diseaseROS

Identifiers

PMID39199163
PMCPMC11351228

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.